|
|
|
|
|
|
|
|
|
|
|
| Secteur analysés : |
osteoarthritis,osteoporosis,pharmacogenomics,...,...
|
| Type d'analyse : |
market size and estimates,market outlook |
| Marché traités : |
|
| |
|
|
|
|
|
|
|
|
| |
 |
|
|
| |
 |
Email: |
|
Choisissez un mot de passe: |
|
Confirmez votre mot de passe: |
|
|
|
|
|
|
| |
|
|
|
| alzheimer,
analgesic,
anxiety,
anxiety disorders,
arthritis,
cancer,
heart failure,
osteoarthritis,
osteoporosis,
parkinson,
pharmacoeconomics,
pharmacogenomics,
rheumatoid arthritis,
sclerosis,
|
| 3 the iuphar compendium of basic principles for pharmacological research in humans introduction 4 chapter 1 ethical considerations 5 2 good clinical practice 11 assessment endpoints kinetics and or dynamics 16 pharmacogenetics pharmacogenomics 27 paediatric drug 34 6 phase i human pharmacology 40 7 follow up drugs after market entry 50 8 bioavailability bioequivalence 55 9 pharmacoeconomics economic evaluation therapies 67 10 utilization 76 cardiovascular disorders 86 hypertensive vascular disease 87 12 lipid lowering agents 106 13 anti atherosclerotic 118 14 heart failure 132 15 arrhythmias 143 neurologic 164 epilepsies convulsive 165 17 headache 183 18 alzheimer s other dementias 212 19 parkinson extrapyramidal 228 20 multiple sclerosis demyelinating diseases 248 mental 263 21 mood 264 22 anxiety 272 23 schizophrenic 278 24 alcoholism nicotine addiction 285 joint 293 25 osteoarthritis |
|
|
| >> Marché Environnement en France >> |
DPLSEN |
|
|
|
|
|
